ROCKAWAY, N.J., Nov. 20, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, is proud to announce that its flagship wellness ...
ROCKAWAY, N.J., June 11, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that its stock is on the preliminary ...
Record revenue for Q3 2025 of $8.7 million, a 33% increase over Q3’2024 Year-to-date revenue of $22.8 million, a 26% increase compared to the first nine months of 2024 Total Cash of $13.2 million as ...
ROCKAWAY, N.J., March 12, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) ("electroCore" or the “Company”), a commercial-stage bioelectronic medicine Company and wellness company, today ...
ROCKAWAY, N.J., May 02, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (“ECOR,” “electroCore,” or the “Company”) (Nasdaq: ECOR), a commercial-stage ...
ROCKAWAY, N.J., Aug. 23, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic and wellness company, today announced that it has been completely vindicated in the ...
WOBURN, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. ("NeuroMetrix” or the "Company”) (Nasdaq: NURO) today announced it has entered into a ...
The shares of bioelectronic medicine company electroCore (ECOR) have been rallying lately on investor optimism surrounding its global expansion strategies. However, because the market remains volatile ...
Bioelectronic medicine player electroCore has set itself up for the next chapter in its story with a $70 million round. The VC wing of Merck was among the investors to return for the series B, which ...
ROCKAWAY, N.J., May 26, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the resignation of its Founder and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results